基本信息
浏览量:8
职业迁徙
个人简介
Research
Few molecules destroy cancer cells without harming healthy tissues. While more targeted cancer therapies are starting to appear, the lack of specificity for tumor cells remains a significant problem. New concepts and innovative approaches are needed to achieve tumor specific cell death and to develop more tumor selective therapies.
HAMLET (Human α-lactalbumin Made LEthal to Tumor cells) is a complex of partially unfolded -lactalbumin and oleic acid that kills tumor cells and immature cells but not fully differentiated healthy cells. We discovered HAMLET by serendipity, in a fraction of human milk that killed lung carcinoma cells and characterized the constituents of the complex. Early in vitro experiments showed that HAMLET has broad anti-tumor activity with a high degree of selectivity.
HAMLET is the first member in a new, expanding family of unfolded protein-lipid complexes that kill a broad range of cancer cells, while sparing normal, differentiated cells. HAMLET thus identifies targets that are highly conserved among cancer cells and whose activation tilts the balance from exaggerated survival to death. This application concerns the structure, cellular targets and in vivo effects of HAMLET. This work is particularly significant in view of HAMLET’s already documented therapeutic effects in patients and animal models.
Few molecules destroy cancer cells without harming healthy tissues. While more targeted cancer therapies are starting to appear, the lack of specificity for tumor cells remains a significant problem. New concepts and innovative approaches are needed to achieve tumor specific cell death and to develop more tumor selective therapies.
HAMLET (Human α-lactalbumin Made LEthal to Tumor cells) is a complex of partially unfolded -lactalbumin and oleic acid that kills tumor cells and immature cells but not fully differentiated healthy cells. We discovered HAMLET by serendipity, in a fraction of human milk that killed lung carcinoma cells and characterized the constituents of the complex. Early in vitro experiments showed that HAMLET has broad anti-tumor activity with a high degree of selectivity.
HAMLET is the first member in a new, expanding family of unfolded protein-lipid complexes that kill a broad range of cancer cells, while sparing normal, differentiated cells. HAMLET thus identifies targets that are highly conserved among cancer cells and whose activation tilts the balance from exaggerated survival to death. This application concerns the structure, cellular targets and in vivo effects of HAMLET. This work is particularly significant in view of HAMLET’s already documented therapeutic effects in patients and animal models.
研究兴趣
论文共 412 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Farhan Haq, Samudra Sabari,Jaromir Háček, Antonín Brisuda,Ines Ambite,Michele Cavalera,Parisa Esmaeili,Murphy Lam Yim Wan,Shahram Ahmadi,Marek Babjuk,Catharina Svanborg
Cancer medicineno. 17 (2024): e70149-e70149
Shahram Ahmadi,Ines Ambite,Antonin Brisuda,Jaromir Hacek, Farhan Haq, Samudra Sabari,Kamala Vanarsa,Chandra Mohan,Marek Babjuk,Catharina Svanborg
Cancer medicineno. 7 (2024)
Scientific reportsno. 1 (2024)
International journal of cancerno. 3 (2023): 584-599
A. Brisuda,J. C. S. Ho,P. S. Kandiyal, J. T-Y Ng,I Ambite,D. S. C. Butler,J. Hacek, M. L. Y. Wan,T. H. Tran,A. Nadeem,A. Hastings,P. Storm,D. L. Fortunati,P. Esmaeili, H. Novotna,J. Hornak,Y. G. Mu,K. H. Mok,M. Babjuk,C. Svanborg
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 412
#Citation: 23559
H-Index: 88
G-Index: 137
Sociability: 7
Diversity: 1
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn